Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative transcriptome analysis of rainbow trout gonadal cells (RTG-2) infected with U and J genogroup infectious hematopoietic necrosis virus. | Front Microbiol | 2022 | 36733771 | PubTator, text mining | PubMed |
| Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma. | Front Immunol | 2022 | 36733386 | PubTator, text mining | PubMed |
| Construction of a DNA damage repair gene signature for predicting prognosis and immune response in breast cancer. | Front Oncol | 2022 | 36713553 | PubTator, text mining | PubMed |
| Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy. | Front Immunol | 2022 | 36713444 | PubTator, text mining | PubMed |
| Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma. | Front Immunol | 2022 | 36713370 | PubTator, text mining | PubMed |
| A cellular senescence-related genes model allows for prognosis and treatment stratification of hepatocellular carcinoma: A bioinformatics analysis and experimental verification. | Front Genet | 2022 | 36712870 | PubTator, text mining | PubMed |
| Plasma protein profiling analysis in patients with atrial fibrillation before and after three different ablation techniques. | Front Cardiovasc Med | 2022 | 36704472 | PubTator, text mining | PubMed |
| Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes. | Front Endocrinol (Lausanne) | 2022 | 36704045 | PubTator, text mining | PubMed |
| Comparative analysis of thoracic and abdominal aortic aneurysms across the segment and species at the single-cell level. | Front Pharmacol | 2022 | 36703732 | PubTator, text mining | PubMed |
| Deciphering the mechanism of Tinospora cordifolia extract on Th17 cells through in-depth transcriptomic profiling and in silico analysis. | Front Pharmacol | 2022 | 36699055 | PubTator, text mining | PubMed |
| YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity. | Front Pharmacol | 2022 | 36686648 | PubTator, text mining | PubMed |
| Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer. | Front Genet | 2022 | 36685937 | PubTator, text mining | PubMed |
| Comparative transcriptomic analysis of long noncoding RNAs in Leishmania-infected human macrophages. | Front Genet | 2022 | 36685903 | PubTator, text mining | PubMed |
| Immune-related gene signature to predict TACE refractoriness in patients with hepatocellular carcinoma based on artificial neural network. | Front Genet | 2022 | 36685822 | PubTator, text mining | PubMed |
| Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer. | Front Surg | 2022 | 36684237 | PubTator, text mining | PubMed |
| Trypanosoma cruzi-specific CD8+ T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: Two decades of research. | Front Cell Infect Microbiol | 2022 | 36683674 | PubTator, text mining | PubMed |
| Discovery and Validation of a SIT1-Related Prognostic Signature Associated with Immune Infiltration in Cutaneous Melanoma. | J Pers Med | 2022 | 36675674 | PubTator, text mining | PubMed |
| B and T lymphocyte attenuator as a C-reactive protein and IgA associated auxiliary diagnostic marker for pulmonary tuberculosis: a case-control study. | Ann Transl Med | 2022 | 36660715 | PubTator, text mining | PubMed |
| A lncRNA-immune checkpoint-related gene signature predicts metastasis-free survival in prostate adenocarcinoma. | Transl Androl Urol | 2022 | 36632155 | PubTator, text mining | PubMed |
| Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma. | Dis Markers | 2022 | 36618968 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=41